Pharma News

Claris Lifesciences Consolidated Q1FY16 PAT Rises 31%

  • Posted on: 14 August 2015
  • By: PharmaTutor News

(NewsVoir); Claris Lifesciences Ltd. (CU) announced its Un-Audited Financial Results for the quarter ended 30th June 2015 at its board meeting held at its registered office in Ahmedabad.

USFDA approves Aprecia's 3D printed drug product, Spritam to treat seizures and epilepsy

  • Posted on: 13 August 2015
  • By: Shalini.Sharma

The US Food and Drug Administration (FDA) has approved Aprecia Pharmaceuticals Company's Spritam (levetiracetam) for oral use as a prescription adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and primary generalised tonic-clonic seizures in adults and children with epilepsy.

FDA Approves Taro’s Keveyis™ (dichlorphenamide) 50 mg Tablets for Primary Hyperkalemic and Hypokalemic Periodic Paralysis

  • Posted on: 12 August 2015
  • By: PharmaTutor News

Taro Pharmaceutical Industries Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Keveyis™ (dichlorphenamide) 50 mg Tablets for the treatment of primary hyperkalemic and hypokalemic periodic paralysis, a group of rare hereditary disorders that cause episodes of muscle weakness or paralysis.[1] Keveyis is the first medicine approved by the FDA for the treatment of primary periodic paralysis, which is estimated to affect approximately 5,000 people in the United States.[2]

New app tracks Health of Heart and Lung patients

  • Posted on: 12 August 2015
  • By: PharmaTutor News

A new smartphone app that monitors patients suffering from chronic cardiopulmonary diseases by analysing the way they walk can warn doctors at the first sign of trouble. Using the health-tracking app, MoveSense, developed by researchers at the University of Illinois at Urbana-Champaign, a patient's oxygen saturation level can be passively monitored with medical accuracy. Oxygen saturation is a standard measure of health status.

IGMPI wins QCI - D. L. Shah Quality Award 2015 - Certificate of Merit

  • Posted on: 12 August 2015
  • By: PharmaTutor News
  • Certificate of Merit for an initiative for knowledge dissemination & training in the area of good manufacturing practices (GMP) By Dr. R. P. Singh (Secretary general, QCI) and Mr. Hari K. Taneja (Trustee, D.L.Shah Trust) in 10th National Quality Conclave held on August 7-8, 2015 at Sirifort Auditorium, New Delhi.

The Annual Flagship event of QCI, the 10th National Quality Conclave “Creating an Ecosystem for World Class Quality in India” with World Health Organization (as Technical Partner for Health Thematic Session) and ASQ (as the Knowledge Partner) held on August 7-8, 2015 in New Delhi. The Quality Conclave 2015 is a platform to know what the world has done and how India can build an Ecosystem of Quality in every sphere of life.

Pages